Market Value3,372,652,431
Total Holdings73
File Date2025-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GERN / Geron Corporation
OCUL / Ocular Therapeutix, Inc.
VERV / Verve Therapeutics, Inc.
PODD / Insulet Corporation
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
BRKR / Bruker Corporation
CBLL / CeriBell, Inc.
BBIO / BridgeBio Pharma, Inc.
LXEO / Lexeo Therapeutics, Inc.
BSX / Boston Scientific Corporation
SKIN / The Beauty Health Company
HLVX / HilleVax, Inc.
ELEV / Elevation Oncology, Inc.
FULC / Fulcrum Therapeutics, Inc.
DXCM / DexCom, Inc.
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
PCVX / Vaxcyte, Inc.
IRWD / Ironwood Pharmaceuticals, Inc.
CGON / CG Oncology, Inc.
CELC / Celcuity Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
EWTX / Edgewise Therapeutics, Inc.
HROW / Harrow, Inc.
VKTX / Viking Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
KNSA / Kiniksa Pharmaceuticals, Ltd.
CSTL / Castle Biosciences, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
XNCR / Xencor, Inc.
IRTC / iRhythm Technologies, Inc.
APLS / Apellis Pharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
XENE / Xenon Pharmaceuticals Inc.
SYRE / Spyre Therapeutics, Inc.
ZURA / Zura Bio Limited
ALGN / Align Technology, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
KRYS / Krystal Biotech, Inc.
KIDS / OrthoPediatrics Corp.
REPL / Replimune Group, Inc.
GKOS / Glaukos Corporation
ARVN / Arvinas, Inc.
AVDL / Avadel Pharmaceuticals plc
US40131MAB54 / CONVERTIBLE ZERO
US670704AJ40 / NuVasive, Inc.
PTGX / Protagonist Therapeutics, Inc.
INSP / Inspire Medical Systems, Inc.
JSPR / Jasper Therapeutics, Inc.
US10806XAD49 / BRIDGEBIO PHARMA INC
IMTX / Immatics N.V.
NVRO / Nevro Corp.
NVCR / NovoCure Limited
FNA / Paragon 28, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
US252131AK39 / CONV. NOTE
RGEN / Repligen Corporation
LUNG / Pulmonx Corporation
US46333XAH17 / CONV. NOTE
US10806XAB82 / Bridgebio Pharma, Inc.
APGE / Apogee Therapeutics, Inc.
BCAX / Bicara Therapeutics Inc.
DNTH / Dianthus Therapeutics, Inc.
AVTE / Aerovate Therapeutics, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
RCUS / Arcus Biosciences, Inc.
PEN / Penumbra, Inc.
EXAS / Exact Sciences Corporation
FDMT / 4D Molecular Therapeutics, Inc.
US232109AD04 / Cutera Inc
CUTERA INC / NOTE 4.000% 6/0 (232109AG3)
DEXCOM INC / NOTE 0.375% 5/1 (252131AM9)
VRDN / Viridian Therapeutics, Inc.
REPLIGEN CORP / NOTE 1.000%12/1 (759916AD1)
AMPHASTAR PHARMACEUTICALS IN / NOTE 2.000% 3/1 (03209RAB9)
ISRG / Intuitive Surgical, Inc.
ALEC / Alector, Inc.
RLAY / Relay Therapeutics, Inc.
LXRX / Lexicon Pharmaceuticals, Inc.
ORKA / Oruka Therapeutics, Inc.
CADL / Candel Therapeutics, Inc.
GH / Guardant Health, Inc.
NUVL / Nuvalent, Inc.
US02081GAB86 / Alphatec Holdings, Inc.
ATEC / Alphatec Holdings, Inc.
SKYE / Skye Bioscience, Inc.
US64049MAB63 / NeoGenomics Inc
TMDX / TransMedics Group, Inc.
SRPT / Sarepta Therapeutics, Inc.
CGEM / Cullinan Therapeutics, Inc.
IOVA / Iovance Biotherapeutics, Inc.
DYN / Dyne Therapeutics, Inc.
KROS / Keros Therapeutics, Inc.